• First product could potentially enter Phase III clinical trials in the U.S. in first half of 2009
  • If successful, technology would be the first tissue engineering product for bladder augmentation
  • Seeking European marketing, sales, and regulatory affairs partner for bladder portfolio
  • FDA regulating techn...
  • This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

    Related Research

    World's first regulatory approval of cell-based meat comes from Singapore

    News Commentary | December 03, 2020

    In a major milestone for the cell‑based meat space, Singapore granted approval to Eat Just's cell‑based chicken. As part of the approval, Eat Just conducted 20 production runs in 1,200 L bioreactors. While Eat Just can now legally sell the cell‑based chicken in Singapore, no details were revealed in... To read more, click here.

    Qidni Labs

    Company Snapshot | September 10, 2021

    The company was started by Morteza Ahmadi in 2014. So far, the company has raised about $1.5 million over three rounds of funding, the latest being a nonequity assistance round in December 2020. Among its investors, we highlight L‑SPARK, 43North, and SOSV. The company makes a mobile kidney ... To read more, click here.


    Company Profile | April 29, 2022

    Prognoix is developing a wearable device, called the Tumeter, which monitors and provides differential analysis for ED Tumeter's core technology is its novel sensing technology that passively measures three clinically established data points of an erection — the engorgement, change of ... Not part of subscription